High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma

High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma

Abstract Background Patients diagnosed with esophageal cancer demonstrate a low overall survival even despite the established multimodal therapy as the current standard of care. Therefore, further biomarkers for patients with high-risk and additional therapy options are needed. NANOG is a transcript...

Full description

Bibliographic Details
Main Authors: Karl Knipper, Alexander I. Damanakis, Su Ir Lyu, Adrian Georg Simon, Isabell Wahler, Christiane J. Bruns, Wolfgang Schröder, Thomas Schmidt, Alexander Quaas
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Cancer
Subjects:
Esophageal adenocarcinoma
NANOG
Multimodal therapy
Personalized medicine
Online Access:https://doi.org/10.1186/s12885-023-11146-0

Internet

https://doi.org/10.1186/s12885-023-11146-0

Similar Items